Form 8-K - Current report:
SEC Accession No. 0001171843-25-003495
Filing Date
2025-05-28
Accepted
2025-05-28 16:05:27
Documents
13
Period of Report
2025-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052825.htm   iXBRL 8-K 42544
2 EXHIBIT 10.1 exh_101.htm EX-10.1 9509
  Complete submission text file 0001171843-25-003495.txt   220243

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE edsa-20250528.xsd EX-101.SCH 3029
4 XBRL LABEL FILE edsa-20250528_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE edsa-20250528_pre.xml EX-101.PRE 22368
16 EXTRACTED XBRL INSTANCE DOCUMENT f8k_052825_htm.xml XML 3503
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 25995438
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)